Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Captopril Effect on Left Ventricle Strain in Duchenne Myodystrophy
NCT06485661Phase 1Recruiting
- Sponsor
- Ain Shams University
- Start
- Jan 2024
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of captopril in Duchenne muscular dystrophy (DMD), sponsored by Ain Shams University. Primary endpoint: Global Longitudinal Strain (GLS) at 6 months. Started Jan 2024; status: recruiting.
02
Drugs
captopril
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on NCT06485661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06485661.